Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Abeona Therapeutics Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 56 | 1 | 48 | −7 |
| Shares | 14.4M | 1 | 30.1M | +15.7M (+108.6%) |
| Value | $104.7M | $7 | $127.8M | +$23.1M (+22.0%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Abeona Therapeutics Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Suvretta Capital Management, LLC | 3,685,503 | $15.6M | 0.64% |
| Vivo Capital, LLC | 1,842,751 | $7.81M | 0.72% |
| Rosalind Advisors, Inc. | 1,750,000 | $7.42M | 5.87% |
| Propel Bio Management, LLC | 1,248,044 | $5.29M | 3.43% |
| 683 Capital Management, LLC | 600,000 | $2.54M | 0.27% |
| Simplify Asset Management Inc. | 408,584 | $1.73M | 0.15% |
| Newtyn Management, LLC | 380,000 | $1.61M | 0.30% |
| Standard Life Aberdeen plc | 126,348 | $535.7K | 0.00% |
| ADAR1 Capital Management, LLC | 113,125 | $479.6K | 0.10% |
| Virtu Financial LLC | 34,615 | $147.0K | 0.01% |
| Oxford Asset Management LLP | 19,059 | $80.8K | 0.08% |
| Activest Wealth Management | 120 | $509 | 0.00% |
Sold out (19)
Institutions that held Abeona Therapeutics Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Goldman Sachs Group Inc | 171,533 | $1.24M |
| Marshall Wace, LLP | 128,903 | $934.5K |
| Man Group plc | 73,824 | $535.2K |
| HRT Financial LP | 69,051 | $500.0K |
| Jane Street Group, LLC | 64,511 | $467.7K |
| Jump Financial, LLC | 25,440 | $184.4K |
| J. Goldman & Co LP | 22,750 | $164.9K |
| Balyasny Asset Management LLC | 19,026 | $137.9K |
| Engineers Gate Manager LP | 17,760 | $128.8K |
| Squarepoint Ops LLC | 14,520 | $105.3K |
| Palumbo Wealth Management LLC | 14,368 | $104.2K |
| Y-Intercept (Hong Kong) Ltd | 14,023 | $101.7K |
| Acadian Asset Management LLC | 12,634 | $91.0K |
| Omers Administration Corp | 12,400 | $89.9K |
| Simplex Trading, LLC | 2,154 | $15.0K |
| Hartford Financial Management Inc. | 720 | $5.22K |
| Truvestments Capital LLC | 51 | $370 |
| FMR LLC | 40 | $290 |
| Macquarie Group Ltd | 760 | $6 |
Not filed for Q2 2024 yet (1)
Institutions that held Abeona Therapeutics Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Highlander Capital Management, LLC | 1 | $7 |